What is the appropriate treatment and vitamin C dosing for scurvy in children of various ages?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 26, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Scurvy Treatment and Vitamin C Dosing in Children

For children with clinical scurvy, treat with 250 mg of oral vitamin C twice daily (500 mg total per day) for 3 weeks 1. This is the most direct guideline-based recommendation available for treating scurvy in the pediatric population.

Treatment Approach

Immediate Management

  • Do not delay treatment if clinical symptoms are present—start vitamin C supplementation immediately while awaiting laboratory confirmation 2
  • Clinical improvement typically occurs rapidly, often within days to weeks of initiating therapy 3, 4, 5

Dosing by Clinical Scenario

Active Scurvy (Symptomatic Disease):

  • Standard treatment dose: 250 mg oral vitamin C twice daily (500 mg/day total) for 3 weeks 1
  • Alternative dosing reported in case literature: 300 mg daily has been used successfully 3
  • Some sources suggest 1 gram daily for 15 days in severe cases 6, though this appears to be extrapolated from adult dosing

Age-Specific Considerations: The guideline evidence does not differentiate dosing by age for treatment of active scurvy—the 250 mg twice daily regimen appears to be applied across pediatric age groups. However, clinical judgment should guide adjustments for very young infants.

Parenteral Nutrition Context

If the child requires parenteral nutrition (different clinical scenario):

  • Infants up to 12 months: 15-25 mg/kg/day 7
  • Older children: 80 mg/day 7

Clinical Recognition

Key Presenting Features to Identify

  • Musculoskeletal: Leg pain, refusal to walk/bear weight, limping, bone pain, pathologic fractures 3, 5, 8, 9, 10
  • Dermatologic: Petechiae, purpura, perifollicular hemorrhages 5, 8
  • Oral: Gingival bleeding, gingival hyperplasia/hypertrophy 5, 10
  • Constitutional: Irritability, failure to thrive, fatigue 3, 11

High-Risk Populations

  • Children with neurodevelopmental disorders (autism spectrum disorder, cerebral palsy) and restricted/selective diets 11, 5, 8, 9
  • Exclusive consumption of plant-based beverages (almond milk) without proper supplementation 3
  • Children with eating disorders or severe dietary restrictions 8
  • Importantly, scurvy can occur across all BMI categories, including children with overweight/obesity 9

Diagnostic Confirmation

Laboratory Testing

  • Plasma vitamin C (ascorbic acid) level < 2 mg/L (< 11.4 μmol/L) confirms deficiency 6
  • Australian data uses < 23 μmol/L as the cutoff for deficiency 8
  • Critical caveat: Do not measure vitamin C during acute inflammation or critical illness—results are difficult to interpret due to acute phase reactant effects 2

Associated Laboratory Findings

  • Microcytic anemia (common) 5, 8
  • Hypocholesterolemia, hypoalbuminemia (nonspecific) 6
  • May have concurrent vitamin D deficiency 5

Radiologic Features

  • Osteopenia, cortical thinning
  • Wimberger ring (dense metaphyseal line)
  • Frankel line (white metaphyseal line)
  • Metaphyseal rarefaction zones
  • Subperiosteal hemorrhage/hematoma
  • Pathologic fractures
  • Periosteal reaction 3, 11

Common Pitfalls

Diagnostic Delays

Recent case series demonstrate that scurvy is frequently misdiagnosed, leading to:

  • Extensive unnecessary workups (MRI, CT, lumbar puncture, endoscopy, EEG) 9
  • Median diagnostic costs of $14,137 per patient in one series 9
  • Delayed recognition despite classic symptoms 5, 8, 10

Why Scurvy is Missed

  • Rarity in developed countries leads to low clinical suspicion 11, 5
  • Symptoms overlap with more serious conditions (malignancy, systemic inflammatory disorders) 10
  • Clinicians may not perform adequate dietary history 8
  • The disease is "often forgotten" despite continued sporadic occurrence 11

Prevention Recommendations

Daily Vitamin C Requirements (Non-Scurvy Context)

  • Infants 0-12 months: 400 IU/day vitamin D is recommended 12, but vitamin C requirements are met through breast milk or formula
  • Children > 12 months: At least 600 IU/day vitamin D 12; vitamin C requirements vary by guideline (40-110 mg/day depending on country) 13

At-Risk Children

  • Ensure adequate vitamin C intake through varied diet including fresh fruits and vegetables 1
  • Plant-based beverages are inappropriate as exclusive nutrition for infants—manufacturers should clearly label this 3
  • Children with neurodevelopmental disorders require proactive dietary assessment and supplementation 8, 9

Monitoring Response to Treatment

  • Clinical improvement should be evident within days to weeks 3, 4, 5
  • Pain and irritability typically resolve quickly
  • Radiologic healing occurs over months
  • Normalize plasma vitamin C levels with treatment
  • Resume weight-bearing and normal development 3, 4

The key to managing scurvy is maintaining high clinical suspicion in children with musculoskeletal symptoms and restricted diets, performing a thorough dietary history, and initiating empiric treatment promptly rather than pursuing extensive diagnostic workups.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.